Although pulmonary fibrosis can occur in the absence of a clear‐cut inciting agent, and
without a clinically clear initial acute inflammatory phase, it is more commonly associated …

Introduction; Pulmonary fibrosis is a frequently reported COVID-19 sequela in which the
exact prevalence and risk factors are yet to be established. This meta-analysis aims to …

Pulmonary fibrosis (PF), a pathological outcome of chronic and acute interstitial lung
diseases associated to compromised wound healing, is a key component of the “post-acute …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) is still increasing
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …

Abstract Background Thousands of Coronavirus Disease 2019 (COVID-19) patients have
been discharged from hospitals Persistent follow-up studies are required to evaluate the …

Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …

At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …

After the COVID-19 outbreak, increasing number of patients worldwide who have survived
COVID-19 continue to battle the symptoms of the illness, long after they have been clinically …

Interstitial pneumonia represents the most common cause of hospitalization for coronavirus
disease 2019 (COVID-19) and may be complicated by acute distress respiratory syndrome …

Clinical characteristics and outcomes of post-COVID-19 pulmo... : Medicine Clinical
characteristics and outcomes of post-COVID-19 pulmonary fibrosis: A case-control study …